Accelerate Diagnostics IncQ) expected to post a loss of 49 cents a share - Earnings Preview
I'm PortAI, I can summarize articles.
Accelerate Diagnostics IncQ) is anticipated to report a quarterly revenue increase of 2.7%, reaching $3 million for the period ending March 31, 2025. However, the company is expected to incur a loss of 49 cents per share. The sole analyst rating for the stock is a "strong buy," with no changes in the mean earnings estimate over the past three months. Results are expected on May 6, 2025.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments